Literature DB >> 8725721

Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease.

G J Miller1, K A Bauer, S Barzegar, J A Cooper, R D Rosenberg.   

Abstract

The haemostatic system was examined in 2951 men aged 50 to 61 years, clinically free of cardiovascular disease, who were ranked according to a risk score for fatal coronary heart disease (CHD). Risk was judged from their serum cholesterol concentration, systolic blood pressure, body mass index and smoking habit. The status of the factor VII-tissue factor pathway was estimated from the plasma levels of factor VII coagulant activity, factor VII antigen and activated factor VII. Activation of factor IX was assessed from the plasma concentration of factor IX activation peptide. Activity within the common pathway was measured as the plasma concentrations of prothrombin fragment 1 + 2 and fibrinopeptide A. All 6 markers of haemostatic status were positively and statistically significantly associated with risk, providing further evidence for a hypercoagulable state in men at high risk for fatal CHD. Plasma fibrinogen and serum triglyceride concentrations were also graded positively with risk.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8725721

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  21 in total

Review 1.  A framework for understanding the training process leading to elite performance.

Authors:  David J Smith
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  F9 Malmö, factor IX and deep vein thrombosis.

Authors:  Irene D Bezemer; Andre R Arellano; Carmen H Tong; Charles M Rowland; Helen A Ireland; Kenneth A Bauer; Joseph Catanese; Pieter H Reitsma; Carine J M Doggen; James J Devlin; Frits R Rosendaal; Lance A Bare
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

3.  Non-recombining chromosome Y haplogroups and centromeric HindIII RFLP in relation to blood pressure in 2,743 middle-aged Caucasian men from the UK.

Authors:  Santiago Rodríguez; Xiao-He Chen; George J Miller; Ian N M Day
Journal:  Hum Genet       Date:  2005-01-27       Impact factor: 4.132

Review 4.  Antithrombotic therapy in acute coronary syndrome: how far up the coagulation cascade will we go?

Authors:  Becky Woodruff; Bruce Sullenger; Richard C Becker
Journal:  Curr Cardiol Rep       Date:  2010-07       Impact factor: 2.931

5.  The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II.

Authors:  P J Talmud; J A Cooper; H Hattori; I P Miller; G J Miller; S E Humphries
Journal:  Diabetologia       Date:  2006-08-18       Impact factor: 10.122

6.  The interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are related to cerebral aneurysms.

Authors:  L Morgan; J Cooper; H Montgomery; N Kitchen; S E Humphries
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-28       Impact factor: 10.154

7.  G20210A Prothrombin gene variant in Turkish patients with angiographically documented coronary artery disease.

Authors:  Fuat Gundogdu; Yekta Gurlertop; Ibrahim Pirim; Sakir Arslan; Mevlut Ikbal; Yahya Islamoglu; Hulya Aksoy; Huseyin Senocak
Journal:  J Thromb Thrombolysis       Date:  2007-03-02       Impact factor: 2.300

8.  Sequence variant on 9p21 is associated with the presence of abdominal aortic aneurysm disease but does not have an impact on aneurysmal expansion.

Authors:  Andrew R Thompson; Jonathan Golledge; Jackie A Cooper; Hany Hafez; Paul E Norman; Steve E Humphries
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

9.  Effect of the factor VII R353Q missense mutation on plasma apolipoprotein B levels: impact of visceral obesity.

Authors:  Marie-Thérèse Berthier; Alain Houde; Jean Bergeron; Denis Prud'homme; Jean-Pierre Després; Marie-Claude Vohl
Journal:  J Hum Genet       Date:  2003-07-08       Impact factor: 3.172

10.  The frequency of an IL-18-associated haplotype in Africans.

Authors:  Simon R Thompson; Steve E Humphries; Mark G Thomas; Rosemary Ekong; Ayele Tarekegn; Endeshaw Bekele; Olivia Creemer; Neil Bradman; Krishna R Veeramah
Journal:  Eur J Hum Genet       Date:  2012-08-29       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.